Home|Journals|Articles by Year|Audio Abstracts
 

Original Research



Ameliorative Effects of Pomegranate Peel Extract and Some of its Bioactive Components against Hyperlipidemia-Induced Atherosclerosis in Male Rats

Enas El-Hussieny, Randa Soliman, Nadia El-Beih.




Abstract
Cited by 1 Articles

Pomegranate (Punica granatum) peel extracts (PPE) have been shown to possess a significant antioxidant activity, which are attributed to its polyphenols including ellagic acid (EA) and punicalagin (PC). Hence, the present study was designed to evaluate the anti-atheroscleotic effect of PPE, EA and PC in high fat diet (HFD) fed male rats. PPE (50 or 100 mg/kg bw), or EA (1mg/kg bw) or PC (7mg/kg bw) was orally administered for six weeks either with standard diet or after induction of hyperlipidemia. At the end of experimental duration, serum lipid profile, atherosclerotic ratios, liver antioxidant/oxidative markers, cardiac enzyme (Lactate dehydrogenase LDH), inflammatory marker (TNF-α) and mRNA expression of CD36 gene were analyzed. Administration of the HFD caused hypercholesterolemia, hypertriglyceridemia and an increase of LDL-C concentrations, whereas it decreased serum HDL-C in comparison to control rats. Also, HFD resulted in a significant elevation in malondialdhyde level and LDH activity in addition to a significant reduction in catalase activity and CD36 expression level. PPE and its purified polyphenols were able to attenuate all the previous injurious effects of HFD through bolstering the antilipidemic and antioxidant effects. In brief, PPE or EA or PC can be beneficial for the suppression of HFD-induced hyperlipidemia, oxidative stress as well as regulation of CD36 expression in rats.

Key words: pomegranate peel, Ellagic acid, Punicalagin, antilipidemic, antioxidant activity, anti-inflammatory, CD36.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.